These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
257 related articles for article (PubMed ID: 24754897)
1. PEG-stabilized bilayer nanodisks as carriers for doxorubicin delivery. Zhang W; Sun J; Liu Y; Tao M; Ai X; Su X; Cai C; Tang Y; Feng Z; Yan X; Chen G; He Z Mol Pharm; 2014 Oct; 11(10):3279-90. PubMed ID: 24754897 [TBL] [Abstract][Full Text] [Related]
2. Nanomicelles based on X-shaped four-armed peglyated distearylglycerol as long circulating system for doxorubicin delivery. Zhang W; Sun J; Fang W; Ai X; Cai C; Tang Y; Su X; Feng Z; Liu Y; Tao M; Yan X; Chen G; He Z Eur J Pharm Sci; 2015 Jan; 66():96-106. PubMed ID: 25446512 [TBL] [Abstract][Full Text] [Related]
3. Doxorubicin-loaded amphiphilic polypeptide-based nanoparticles as an efficient drug delivery system for cancer therapy. Lv S; Li M; Tang Z; Song W; Sun H; Liu H; Chen X Acta Biomater; 2013 Dec; 9(12):9330-42. PubMed ID: 23958784 [TBL] [Abstract][Full Text] [Related]
4. Star-shape copolymer of lysine-linked di-tocopherol polyethylene glycol 2000 succinate for doxorubicin delivery with reversal of multidrug resistance. Wang J; Sun J; Chen Q; Gao Y; Li L; Li H; Leng D; Wang Y; Sun Y; Jing Y; Wang S; He Z Biomaterials; 2012 Oct; 33(28):6877-88. PubMed ID: 22770799 [TBL] [Abstract][Full Text] [Related]
5. Peptide-conjugated PAMAM for targeted doxorubicin delivery to transferrin receptor overexpressed tumors. Han L; Huang R; Liu S; Huang S; Jiang C Mol Pharm; 2010 Dec; 7(6):2156-65. PubMed ID: 20857964 [TBL] [Abstract][Full Text] [Related]
6. Redox and pH dual responsive poly(amidoamine) dendrimer-poly(ethylene glycol) conjugates for intracellular delivery of doxorubicin. Hu W; Qiu L; Cheng L; Hu Q; Liu Y; Hu Z; Chen D; Cheng L Acta Biomater; 2016 May; 36():241-53. PubMed ID: 26995505 [TBL] [Abstract][Full Text] [Related]
7. PEG-doxorubicin conjugates: influence of polymer structure on drug release, in vitro cytotoxicity, biodistribution, and antitumor activity. Veronese FM; Schiavon O; Pasut G; Mendichi R; Andersson L; Tsirk A; Ford J; Wu G; Kneller S; Davies J; Duncan R Bioconjug Chem; 2005; 16(4):775-84. PubMed ID: 16029018 [TBL] [Abstract][Full Text] [Related]
8. Polyethylene glycol-modified arachidyl chitosan-based nanoparticles for prolonged blood circulation of doxorubicin. Termsarasab U; Yoon IS; Park JH; Moon HT; Cho HJ; Kim DD Int J Pharm; 2014 Apr; 464(1-2):127-34. PubMed ID: 24451239 [TBL] [Abstract][Full Text] [Related]
9. Stimuli-responsive PEGylated prodrugs for targeted doxorubicin delivery. Xu M; Qian J; Liu X; Liu T; Wang H Mater Sci Eng C Mater Biol Appl; 2015 May; 50():341-7. PubMed ID: 25746279 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and in vitro and in vivo evaluations of poly(ethylene glycol)-block-poly(4-vinylbenzylphosphonate) magnetic nanoparticles containing doxorubicin as a potential targeted drug delivery system. Hałupka-Bryl M; Asai K; Thangavel S; Bednarowicz M; Krzyminiewski R; Nagasaki Y Colloids Surf B Biointerfaces; 2014 Jun; 118():140-7. PubMed ID: 24769390 [TBL] [Abstract][Full Text] [Related]
11. pH-Responsive chimaeric pepsomes based on asymmetric poly(ethylene glycol)-b-poly(l-leucine)-b-poly(l-glutamic acid) triblock copolymer for efficient loading and active intracellular delivery of doxorubicin hydrochloride. Chen P; Qiu M; Deng C; Meng F; Zhang J; Cheng R; Zhong Z Biomacromolecules; 2015 Apr; 16(4):1322-30. PubMed ID: 25759951 [TBL] [Abstract][Full Text] [Related]
12. Robust PEGylated hyaluronic acid nanoparticles as the carrier of doxorubicin: mineralization and its effect on tumor targetability in vivo. Han HS; Lee J; Kim HR; Chae SY; Kim M; Saravanakumar G; Yoon HY; You DG; Ko H; Kim K; Kwon IC; Park JC; Park JH J Control Release; 2013 Jun; 168(2):105-14. PubMed ID: 23474029 [TBL] [Abstract][Full Text] [Related]
13. Charge-conversional PEG-polypeptide polyionic complex nanoparticles from simple blending of a pair of oppositely charged block copolymers as an intelligent vehicle for efficient antitumor drug delivery. Lv S; Song W; Tang Z; Li M; Yu H; Hong H; Chen X Mol Pharm; 2014 May; 11(5):1562-74. PubMed ID: 24606535 [TBL] [Abstract][Full Text] [Related]
14. A novel delivery system of doxorubicin with high load and pH-responsive release from the nanoparticles of poly (α,β-aspartic acid) derivative. Wang X; Wu G; Lu C; Zhao W; Wang Y; Fan Y; Gao H; Ma J Eur J Pharm Sci; 2012 Aug; 47(1):256-64. PubMed ID: 22522116 [TBL] [Abstract][Full Text] [Related]
15. Preparation and characterization of HA-PEG-PCL intelligent core-corona nanoparticles for delivery of doxorubicin. Yadav AK; Mishra P; Jain S; Mishra P; Mishra AK; Agrawal GP J Drug Target; 2008 Jul; 16(6):464-78. PubMed ID: 18604659 [TBL] [Abstract][Full Text] [Related]
16. pH-sensitive Laponite(®)/doxorubicin/alginate nanohybrids with improved anticancer efficacy. Gonçalves M; Figueira P; Maciel D; Rodrigues J; Qu X; Liu C; Tomás H; Li Y Acta Biomater; 2014 Jan; 10(1):300-7. PubMed ID: 24075886 [TBL] [Abstract][Full Text] [Related]
17. Selenium-functionalized liposomes for systemic delivery of doxorubicin with enhanced pharmacokinetics and anticancer effect. Xie Q; Deng W; Yuan X; Wang H; Ma Z; Wu B; Zhang X Eur J Pharm Biopharm; 2018 Jan; 122():87-95. PubMed ID: 29032193 [TBL] [Abstract][Full Text] [Related]
18. Gold nanoparticles with a monolayer of doxorubicin-conjugated amphiphilic block copolymer for tumor-targeted drug delivery. Prabaharan M; Grailer JJ; Pilla S; Steeber DA; Gong S Biomaterials; 2009 Oct; 30(30):6065-75. PubMed ID: 19674777 [TBL] [Abstract][Full Text] [Related]
19. Poly(ethyleneglycol)-b-poly(ε-caprolactone-co-γ-hydroxyl-ε- caprolactone) bearing pendant hydroxyl groups as nanocarriers for doxorubicin delivery. Chang L; Deng L; Wang W; Lv Z; Hu F; Dong A; Zhang J Biomacromolecules; 2012 Oct; 13(10):3301-10. PubMed ID: 22931197 [TBL] [Abstract][Full Text] [Related]
20. Reduction-responsive disassemblable core-cross-linked micelles based on poly(ethylene glycol)-b-poly(N-2-hydroxypropyl methacrylamide)-lipoic acid conjugates for triggered intracellular anticancer drug release. Wei R; Cheng L; Zheng M; Cheng R; Meng F; Deng C; Zhong Z Biomacromolecules; 2012 Aug; 13(8):2429-38. PubMed ID: 22746534 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]